Free Trial

Autolus Therapeutics (AUTL) News Today

Autolus Therapeutics logo
$1.65 +0.08 (+5.10%)
Closing price 04:00 PM Eastern
Extended Trading
$1.64 -0.01 (-0.61%)
As of 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AUTL Latest News

Autolus Therapeutics plc stock logo
Cetera Investment Advisers Increases Holdings in Autolus Therapeutics plc (NASDAQ:AUTL)
Cetera Investment Advisers grew its holdings in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 169.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 356,222 shares of the company's stock after buying an
Autolus Therapeutics plc stock logo
247,089 Shares in Autolus Therapeutics plc (NASDAQ:AUTL) Bought by Point72 Asset Management L.P.
Point72 Asset Management L.P. purchased a new position in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 247,089 shares of the company's stock, valued at appro
Autolus Therapeutics plc stock logo
TFG Asset Management GP Ltd Buys 250,000 Shares of Autolus Therapeutics plc (NASDAQ:AUTL)
TFG Asset Management GP Ltd increased its stake in Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 3.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,250,000 shares of the
Autolus Therapeutics plc stock logo
Autolus Therapeutics (NASDAQ:AUTL) Issues Quarterly Earnings Results
Autolus Therapeutics (NASDAQ:AUTL - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.26) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.24) by ($0.02).
Autolus Therapeutics plc stock logo
Autolus Therapeutics plc (NASDAQ:AUTL) Receives Consensus Rating of "Buy" from Analysts
Autolus Therapeutics plc (NASDAQ:AUTL - Get Free Report) has earned an average recommendation of "Buy" from the six brokerages that are presently covering the stock, MarketBeat.com reports. Six research analysts have rated the stock with a buy recommendation. The average 12-month price target amon
Autolus Therapeutics plc stock logo
Axa S.A. Makes New Investment in Autolus Therapeutics plc (NASDAQ:AUTL)
Axa S.A. purchased a new position in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 1,824,685 shares of the company's stock, valued a
Autolus Therapeutics plc stock logo
Deep Track Capital LP Cuts Holdings in Autolus Therapeutics plc (NASDAQ:AUTL)
Deep Track Capital LP decreased its holdings in Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 6.9% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 14,218,903 shares of the company's stock after
Autolus Therapeutics plc stock logo
Price T Rowe Associates Inc. MD Sells 902,261 Shares of Autolus Therapeutics plc (NASDAQ:AUTL)
Price T Rowe Associates Inc. MD lowered its stake in Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 23.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,939,241 shares of the company's stock after selling 902,261 shares
Autolus Therapeutics plc stock logo
Autolus Therapeutics (AUTL) Projected to Post Quarterly Earnings on Thursday
Autolus Therapeutics (NASDAQ:AUTL) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-autolus-therapeutics-plc-stock/)
Autolus Therapeutics plc stock logo
Autolus Therapeutics plc (NASDAQ:AUTL) Stake Boosted by Renaissance Technologies LLC
Renaissance Technologies LLC increased its position in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 146.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 618,942 shar
Autolus Therapeutics plc stock logo
Legal & General Group Plc Buys 237,224 Shares of Autolus Therapeutics plc (NASDAQ:AUTL)
Legal & General Group Plc grew its stake in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 392.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 297,736 shares of the company's stock after buying an additional 237,22
Autolus Therapeutics plc stock logo
Walleye Capital LLC Trims Stock Position in Autolus Therapeutics plc (NASDAQ:AUTL)
Walleye Capital LLC trimmed its holdings in Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 92.9% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 75,940 shares of the company's stock after selling 986,453 shares during the period. Walleye Capital LLC
Autolus Therapeutics plc stock logo
Q1 Earnings Estimate for AUTL Issued By William Blair
Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) - Analysts at William Blair issued their Q1 2026 EPS estimates for shares of Autolus Therapeutics in a report issued on Wednesday, April 23rd. William Blair analyst M. Phipps anticipates that the company will post earnings of ($0.27) per share
Autolus Therapeutics plc stock logo
JPMorgan Chase & Co. Trims Holdings in Autolus Therapeutics plc (NASDAQ:AUTL)
JPMorgan Chase & Co. lowered its position in Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 16.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,071,533 shares of the company's stock after selling 213,175 sh
Autolus Therapeutics plc stock logo
Eversept Partners LP Sells 307,663 Shares of Autolus Therapeutics plc (NASDAQ:AUTL)
Eversept Partners LP decreased its stake in Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 75.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 98,895 shares of the company's stock after selling 307,663
Autolus Therapeutics plc stock logo
Avoro Capital Advisors LLC Trims Holdings in Autolus Therapeutics plc (NASDAQ:AUTL)
Avoro Capital Advisors LLC cut its holdings in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 19.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 9,910,642 shares of the company's stock after selling 2,435,0
Autolus Therapeutics plc stock logo
Autolus Therapeutics plc (NASDAQ:AUTL) Receives Average Recommendation of "Buy" from Brokerages
Autolus Therapeutics plc (NASDAQ:AUTL - Get Free Report) has been assigned a consensus rating of "Buy" from the six analysts that are currently covering the firm, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month target price among
Autolus Therapeutics plc stock logo
Autolus Therapeutics' (AUTL) Buy Rating Reiterated at Needham & Company LLC
Needham & Company LLC restated a "buy" rating and set a $10.00 price objective on shares of Autolus Therapeutics in a report on Thursday.
Autolus Therapeutics plc stock logo
Autolus Therapeutics plc (NASDAQ:AUTL) Shares Acquired by Wellington Management Group LLP
Wellington Management Group LLP increased its holdings in Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 4.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 25,345,680 shares of the company's stock after acqu
Autolus Therapeutics plc stock logo
Truist Financial Lowers Autolus Therapeutics (NASDAQ:AUTL) Price Target to $10.00
Truist Financial lowered their target price on Autolus Therapeutics from $11.00 to $10.00 and set a "buy" rating on the stock in a research note on Tuesday.
Autolus Therapeutics price target lowered to $10 from $11 at Truist
Autolus Therapeutics plc stock logo
BIT Capital GmbH Buys 379,050 Shares of Autolus Therapeutics plc (NASDAQ:AUTL)
BIT Capital GmbH increased its position in Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 147.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 636,979 shares of the company's stock after acquiring an additional 37
Autolus Therapeutics plc stock logo
191,429 Shares in Autolus Therapeutics plc (NASDAQ:AUTL) Bought by EntryPoint Capital LLC
EntryPoint Capital LLC purchased a new stake in Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 191,429 shares of the company's stock, valued at approximately $450,000.
Autolus Therapeutics plc stock logo
Equities Analysts Offer Predictions for AUTL FY2028 Earnings
Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) - Investment analysts at William Blair issued their FY2028 earnings per share estimates for shares of Autolus Therapeutics in a research note issued to investors on Thursday, March 20th. William Blair analyst M. Phipps forecasts that the compan
Autolus Therapeutics plc stock logo
Autolus Therapeutics plc (NASDAQ:AUTL) Given Consensus Recommendation of "Buy" by Brokerages
Shares of Autolus Therapeutics plc (NASDAQ:AUTL - Get Free Report) have been given an average recommendation of "Buy" by the six research firms that are presently covering the firm, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy rating. The average 1 year price o
Autolus Therapeutics plc stock logo
Wells Fargo & Company Has Lowered Expectations for Autolus Therapeutics (NASDAQ:AUTL) Stock Price
Wells Fargo & Company lowered their target price on Autolus Therapeutics from $8.00 to $6.00 and set an "overweight" rating for the company in a research note on Friday.
Get Autolus Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AUTL and its competitors with MarketBeat's FREE daily newsletter.

AUTL Media Mentions By Week

AUTL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AUTL
News Sentiment

0.92

0.93

Average
Medical
News Sentiment

AUTL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AUTL Articles
This Week

9

3

AUTL Articles
Average Week

Get Autolus Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AUTL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:AUTL) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners